Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunopathology of galectin-3: an increasingly promising target in COVID-19
John L. Caniglia, Swapna Asuthkar, Andrew J. Tsung, et al.
F1000Research (2020) Vol. 9, pp. 1078-1078
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

The glycosylation in SARS-CoV-2 and its receptor ACE2
Yanqiu Gong, Suideng Qin, Lunzhi Dai, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 166
SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care
Clemens Gutmann, Kaloyan Takov, Sean A. Burnap, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 148
The role of galectins in immunity and infection
Fu‐Tong Liu, Sean R. Stowell
Nature reviews. Immunology (2023) Vol. 23, Iss. 8, pp. 479-494
Open Access | Times Cited: 137
Targeting galectin-3 in inflammatory and fibrotic diseases
Selena Bouffette, Iuliana Botez, Frédéric De Ceuninck
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 8, pp. 519-531
Open Access | Times Cited: 63
Covid‐19 and oral diseases: Crosstalk, synergy or association?
Daniela Atili Brandini, Aline Satie Takamiya, Pari Thakkar, et al.
Reviews in Medical Virology (2021) Vol. 31, Iss. 6
Open Access | Times Cited: 95
Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection
Najmeh Bozorgmehr, Siavash Mashhouri, Eliana Perez Rosero, et al.
mBio (2021) Vol. 12, Iss. 3
Open Access | Times Cited: 77
Galectin-3 as a potential prognostic biomarker of severe COVID-19 in SARS-CoV-2 infected patients
Eduardo Cervantes-Álvarez, Nathaly Limon‐de la Rosa, Moisés Salgado-de la Mora, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 52
Development of Galectin-3 Targeting Drugs for Therapeutic Applications in Various Diseases
Rakin Ahmed, Khairul Anam, Hafiz Ahmed
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8116-8116
Open Access | Times Cited: 24
Galectin-3 as prognostic biomarker in patients with COVID-19 acute respiratory failure
Andrea Portacci, Fabrizio Diaferia, Carla Santomasi, et al.
Respiratory Medicine (2021) Vol. 187, pp. 106556-106556
Open Access | Times Cited: 42
The S1 Subunit of the SARS-CoV-2 Spike Protein Activates Human Monocytes to Produce Cytokines Linked to COVID-19: Relevance to Galectin-3
John T. Schroeder, Anja P. Bieneman
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 37
A multi-tissue study of immune gene expression profiling highlights the key role of the nasal epithelium in COVID-19 severity
Alberto Gómez‐Carballa, Irene Rivero‐Calle, Jacobo Pardo‐Seco, et al.
Environmental Research (2022) Vol. 210, pp. 112890-112890
Open Access | Times Cited: 35
An Inhaled Galectin-3 Inhibitor in COVID-19 Pneumonitis: A Phase Ib/IIa Randomized Controlled Clinical Trial (DEFINE)
Erin Gaughan, Tom Quinn, Andrew C. Mills, et al.
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 207, Iss. 2, pp. 138-149
Open Access | Times Cited: 28
Adipokines as Diagnostic and Prognostic Markers for the Severity of COVID-19
Thomas Grewal, Christa Buechler
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1302-1302
Open Access | Times Cited: 16
Interleukin-18 Is a Potential Biomarker to Discriminate Active Adult-Onset Still’s Disease From COVID-19
Po‐Ku Chen, Joung‐Liang Lan, Po‐Hao Huang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 40
Assessment of Galectin-1, Galectin-3, and Prostaglandin E2 Levels in Patients with COVID-19
Sümeyye Kazancıoğlu, Fatma Yılmaz, Aliye Baştuğ, et al.
Japanese Journal of Infectious Diseases (2021) Vol. 74, Iss. 6, pp. 530-536
Open Access | Times Cited: 36
Inhibitory Immune Checkpoint Receptors and Ligands as Prognostic Biomarkers in COVID-19 Patients
Mohammad A. Al-Mterin, Alhasan Alsalman, Eyad Elkord
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 23
Molecular mechanisms of COVID-19-induced pulmonary fibrosis and epithelial-mesenchymal transition
Peng Pi, Zhipeng Zeng, Liqing Zeng, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14
Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients
Leila B. Giron, Harsh Dweep, Xiangfan Yin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 33
Galectin-8, cytokines, and the storm
Yehiel Zick
Biochemical Society Transactions (2021) Vol. 50, Iss. 1, pp. 135-149
Open Access | Times Cited: 29
Beneficial Effects of Mineralocorticoid Receptor Pathway Blockade against Endothelial Inflammation Induced by SARS-CoV-2 Spike Protein
Eva Jover, Lara Matilla, Mattie Garaikoetxea, et al.
Biomedicines (2021) Vol. 9, Iss. 6, pp. 639-639
Open Access | Times Cited: 27
Cellular and Molecular Mechanism of Pulmonary Fibrosis Post-COVID-19: Focus on Galectin-1, -3, -8, -9
Daniela Adriana Oatis, Erika Simon-Repolski, Cornel Baltă, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8210-8210
Open Access | Times Cited: 22
Role of aging in Blood–Brain Barrier dysfunction and susceptibility to SARS-CoV-2 infection: impacts on neurological symptoms of COVID-19
Daniel Adesse, Luis Gladulich, Liandra Alvarez-Rosa, et al.
Fluids and Barriers of the CNS (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 22
The Pivotal Role of Galectin-3 in Viral Infection: A Multifaceted Player in Host–Pathogen Interactions
Bojana Stojanović, Bojan Stojanović, Jelena Milovanović, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9617-9617
Open Access | Times Cited: 12
Insights into the Role of Galectin-3 as a Diagnostic and Prognostic Biomarker of Atrial Fibrillation
Yasmin Mohtasham Kia, Alessandro Cannavò, Pegah Bahiraie, et al.
Disease Markers (2023) Vol. 2023, pp. 1-13
Open Access | Times Cited: 11
Galectin-1 as the new player in staging and prognosis of COVID-19
Sofija Marković, Nevena Gajović, Milena Jurišević, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top